
Chinese General Practice ›› 2027, Vol. 30 ›› Issue (01): 73-82.DOI: 10.12114/j.issn.1007-9572.2026.0040
• Article • Previous Articles
Received:2026-01-14
Revised:2026-06-27
Published:2027-01-05
Online:2026-11-17
Contact:
LI Ruibin, WANG Wei
通讯作者:
李瑞斌, 王玮
作者简介:作者贡献:
刘涛负责数据的收集与整理、统计学处理、图表绘制与展示,撰写论文;李瑞斌参与研究方案设计,负责文章质量控制与审查;王玮提出研究思路,负责设计研究方案,修订论文。所有作者阅读并同意最终文本,对文章整体负责。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2026.0040
| 血管狭窄程度 | 基础评分(分) | 病变部位 | 相应系数 |
|---|---|---|---|
| 1%~25% | 1 | 左主干 | 5.0 |
| 26%~50% | 2 | 左前降支或回旋支近段 | 2.5 |
| 51%~75% | 4 | 左前降支中段 | 1.5 |
| 76%~90% | 8 | 左前降支远段 | 1.0 |
| 91%~99% | 16 | 左回旋支中、远段 | 1.0 |
| 100% | 32 | 右冠状动脉 | 1.0 |
| 其余小分支 | 0.5 |
Table 1 GS calculation rules
| 血管狭窄程度 | 基础评分(分) | 病变部位 | 相应系数 |
|---|---|---|---|
| 1%~25% | 1 | 左主干 | 5.0 |
| 26%~50% | 2 | 左前降支或回旋支近段 | 2.5 |
| 51%~75% | 4 | 左前降支中段 | 1.5 |
| 76%~90% | 8 | 左前降支远段 | 1.0 |
| 91%~99% | 16 | 左回旋支中、远段 | 1.0 |
| 100% | 32 | 右冠状动脉 | 1.0 |
| 其余小分支 | 0.5 |
| 组别 | 例数 | 性别(男/女) | 年龄[例(%)] | 吸烟史[例(%)] | 饮酒史[例(%)] | 高血压[例(%)] | T2DM [例(%)] | BMI[M(P25,P75),kg/m2] | |
|---|---|---|---|---|---|---|---|---|---|
| <55岁 | ≥55岁 | ||||||||
| GS<65分组 | 169 | 126/43 | 60(35.50) | 109(64.50) | 57(33.73) | 21(12.43) | 111(65.68) | 77(45.56) | 26.7(24.6,27.7) |
| GS≥65分组 | 71 | 58/13 | 33(46.48) | 38(53.52) | 29(40.85) | 8(11.27) | 41(57.75) | 43(60.56) | 26.7(24.5,27.7) |
| 检验统计量值 | 1.422a | 2.538a | 1.101a | 0.063a | 1.355a | 4.500a | -0.038 | ||
| P值 | 0.233 | 0.111 | 0.294 | 0.802 | 0.244 | 0.034 | 0.790 | ||
| 组别 | WBC计数[M(P25,P75),×109/L] | Hb ( | PLT计数( | RDW-SD[M(P25,P75),fL] | RDW-CV[M(P25,P75),%] | MCV ( | Scr[M(P25,P75),μmol/L] | ||
| GS<65分组 | 7.53 (6.25,9.21) | 149.01±13.49 | 222.53±54.46 | 41.40 (39.85,42.50) | 12.60 (12.20,13.00) | 89.26±4.13 | 73.00 (63.00,83.00) | ||
| GS≥65分组 | 8.53 (7.06,10.77) | 149.69±16.25 | 229.69±52.95 | 41.90 (40.80,43.70) | 12.70 (12.30,13.00) | 90.93±3.80 | 75.00 (64.00,85.00) | ||
| 检验统计量值 | -3.161 | -0.334b | -0.938b | -3.299 | -0.952 | -2.936b | -1.031 | ||
| P值 | 0.002 | 0.739 | 0.349 | 0.001 | 0.341 | 0.004 | 0.302 | ||
| 组别 | ALB ( | FBG[M(P25,P75),mmol/L] | TG[M(P25,P75),mmol/L] | TC( | HDL-C[M(P25,P75),mmol/L] | LDL-C ( | TyG ( | ||
| GS<65分组 | 41.73±3.39 | 5.8(5.1,7.9) | 1.71(1.29,2.13) | 4.16±0.92 | 0.99(0.85,1.16) | 2.60±0.80 | 9.07±0.52 | ||
| GS≥65分组 | 42.36±2.93 | 7.4(5.4,10.1) | 2.08(1.69,2.92) | 4.83±1.03 | 0.99(0.86,1.24) | 3.05±0.89 | 9.51±0.57 | ||
| 检验统计量值 | -1.356b | -3.537 | -4.193 | -4.921b | -0.511 | -3.836b | -5.806b | ||
| P值 | 0.176 | <0.001 | <0.001 | <0.001 | 0.609 | <0.001 | <0.001 | ||
Table 2 Comparison of clinical data between the GS<65 group and the GS≥65 group
| 组别 | 例数 | 性别(男/女) | 年龄[例(%)] | 吸烟史[例(%)] | 饮酒史[例(%)] | 高血压[例(%)] | T2DM [例(%)] | BMI[M(P25,P75),kg/m2] | |
|---|---|---|---|---|---|---|---|---|---|
| <55岁 | ≥55岁 | ||||||||
| GS<65分组 | 169 | 126/43 | 60(35.50) | 109(64.50) | 57(33.73) | 21(12.43) | 111(65.68) | 77(45.56) | 26.7(24.6,27.7) |
| GS≥65分组 | 71 | 58/13 | 33(46.48) | 38(53.52) | 29(40.85) | 8(11.27) | 41(57.75) | 43(60.56) | 26.7(24.5,27.7) |
| 检验统计量值 | 1.422a | 2.538a | 1.101a | 0.063a | 1.355a | 4.500a | -0.038 | ||
| P值 | 0.233 | 0.111 | 0.294 | 0.802 | 0.244 | 0.034 | 0.790 | ||
| 组别 | WBC计数[M(P25,P75),×109/L] | Hb ( | PLT计数( | RDW-SD[M(P25,P75),fL] | RDW-CV[M(P25,P75),%] | MCV ( | Scr[M(P25,P75),μmol/L] | ||
| GS<65分组 | 7.53 (6.25,9.21) | 149.01±13.49 | 222.53±54.46 | 41.40 (39.85,42.50) | 12.60 (12.20,13.00) | 89.26±4.13 | 73.00 (63.00,83.00) | ||
| GS≥65分组 | 8.53 (7.06,10.77) | 149.69±16.25 | 229.69±52.95 | 41.90 (40.80,43.70) | 12.70 (12.30,13.00) | 90.93±3.80 | 75.00 (64.00,85.00) | ||
| 检验统计量值 | -3.161 | -0.334b | -0.938b | -3.299 | -0.952 | -2.936b | -1.031 | ||
| P值 | 0.002 | 0.739 | 0.349 | 0.001 | 0.341 | 0.004 | 0.302 | ||
| 组别 | ALB ( | FBG[M(P25,P75),mmol/L] | TG[M(P25,P75),mmol/L] | TC( | HDL-C[M(P25,P75),mmol/L] | LDL-C ( | TyG ( | ||
| GS<65分组 | 41.73±3.39 | 5.8(5.1,7.9) | 1.71(1.29,2.13) | 4.16±0.92 | 0.99(0.85,1.16) | 2.60±0.80 | 9.07±0.52 | ||
| GS≥65分组 | 42.36±2.93 | 7.4(5.4,10.1) | 2.08(1.69,2.92) | 4.83±1.03 | 0.99(0.86,1.24) | 3.05±0.89 | 9.51±0.57 | ||
| 检验统计量值 | -1.356b | -3.537 | -4.193 | -4.921b | -0.511 | -3.836b | -5.806b | ||
| P值 | 0.176 | <0.001 | <0.001 | <0.001 | 0.609 | <0.001 | <0.001 | ||
| 组别 | 例数 | RDW-SD [M(P25,P75),fL] | TyG[M(P25,P75)] | TyG×RDW-SD( | TyG×MCV ( | RDW-SD×TC( | RDW-SD×LDL-C( |
|---|---|---|---|---|---|---|---|
| 不合并T2DM的CHD组 | 120 | 41.55(40.00,42.50) | 8.90(8.58,9.22) | 368.92±30.11 | 796.29±56.47 | 179.50±42.29 | 112.98±34.69 |
| 合并T2DM的CHD组 | 120 | 41.55(40.30,43.05) | 9.47(9.21,9.86) | 396.98±31.57 | 855.70±62.44 | 184.11±47.03 | 115.32±39.42 |
| t(Z)值 | -1.382a | -7.883a | -7.046 | -7.730 | -0.797 | -0.488 | |
| P值 | 0.167 | <0.001 | <0.001 | <0.001 | 0.426 | 0.626 |
Table 3 Comparison of main research indicators between CHD group without T2DM and CHD group with T2DM
| 组别 | 例数 | RDW-SD [M(P25,P75),fL] | TyG[M(P25,P75)] | TyG×RDW-SD( | TyG×MCV ( | RDW-SD×TC( | RDW-SD×LDL-C( |
|---|---|---|---|---|---|---|---|
| 不合并T2DM的CHD组 | 120 | 41.55(40.00,42.50) | 8.90(8.58,9.22) | 368.92±30.11 | 796.29±56.47 | 179.50±42.29 | 112.98±34.69 |
| 合并T2DM的CHD组 | 120 | 41.55(40.30,43.05) | 9.47(9.21,9.86) | 396.98±31.57 | 855.70±62.44 | 184.11±47.03 | 115.32±39.42 |
| t(Z)值 | -1.382a | -7.883a | -7.046 | -7.730 | -0.797 | -0.488 | |
| P值 | 0.167 | <0.001 | <0.001 | <0.001 | 0.426 | 0.626 |
| 变量 | 赋值 |
|---|---|
| GS | <65分=0,≥65分=1 |
| 性别 | 女=0,男=1 |
| 年龄 | <55岁=0,≥55岁=1 |
| 吸烟史 | 否=0,是=1 |
| 饮酒史 | 否=0,是=1 |
| 高血压 | 否=0,是=1 |
| 糖尿病 | 否=0,是=1 |
| 计量资料 | 实测值 |
Table 4 Assignment of each study variable
| 变量 | 赋值 |
|---|---|
| GS | <65分=0,≥65分=1 |
| 性别 | 女=0,男=1 |
| 年龄 | <55岁=0,≥55岁=1 |
| 吸烟史 | 否=0,是=1 |
| 饮酒史 | 否=0,是=1 |
| 高血压 | 否=0,是=1 |
| 糖尿病 | 否=0,是=1 |
| 计量资料 | 实测值 |
| 因素 | 不合并T2DM的CHD组 | 合并T2DM的CHD组 | ||
|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 性别 | 0.779(0.263~2.308) | 0.653 | 0.571(0.229~1.425) | 0.230 |
| 年龄 | 0.965(0.919~1.014) | 0.160 | 0.935(0.882~0.993) | 0.027 |
| 吸烟史 | 0.838(0.349~2.013) | 0.693 | 0.693(0.381~1.509) | 0.355 |
| 饮酒史 | 1.073(0.277~4.161) | 0.919 | 1.625(0.484~5.454) | 0.432 |
| 高血压 | 0.792(0.321~1.952) | 0.612 | 2.386(1.098~5.184) | 0.028 |
| BMI | 0.963(0.827~1.123) | 0.634 | 0.980(0.855~1.124) | 0.775 |
| WBC计数 | 1.247(1.061~1.466) | 0.007 | 1.127(0.993~1.280) | 0.064 |
| Hb | 1.011(0.980~1.043) | 0.496 | 0.996(0.971~1.022) | 0.762 |
| PLT计数 | 1.009(1.001~1.017) | 0.031 | 0.998(0.991~1.005) | 0.641 |
| RDW-SD | 1.162(0.949~1.422) | 0.146 | 1.271(1.056~1.529) | 0.011 |
| RDW-CV | 1.047(0.513~2.137) | 0.900 | 1.284(0.722~2.283) | 0.395 |
| MCV | 1.104(0.981~1.241) | 0.100 | 1.091(0.997~1.194) | 0.058 |
| Scr | 1.028(0.996~1.060) | 0.087 | 1.012(0.993~1.032) | 0.221 |
| ALB | 1.121(0.977~1.286) | 0.103 | 1.024(0.912~1.149) | 0.690 |
| FBG | 1.475(0.999~2.180) | 0.051 | 1.193(1.041~1.368) | 0.011 |
| TG | 1.537(1.019~2.318) | 0.040 | 2.315(1.404~3.817) | 0.001 |
| TC | 2.108(1.256~3.538) | 0.005 | 1.997(1.316~3.030) | 0.001 |
| HDL-C | 2.467(0.371~16.425) | 0.350 | 1.193(0.296~4.810) | 0.804 |
| LDL-C | 1.936(1.092~3.433) | 0.024 | 1.853(1.178~2.914) | 0.008 |
| TyG | 2.934(1.203~7.158) | 0.018 | 10.448(3.501~31.178) | <0.001 |
| TyG×RDW-SD | 1.019(1.004~1.034) | 0.011 | 1.048(1.027~1.070) | <0.001 |
| TyG×MCV | 1.011(1.003~1.019) | 0.005 | 1.018(1.010~1.027) | <0.001 |
| RDW-SD×TC | 1.017(1.006~1.029) | 0.003 | 1.018(1.008~1.028) | <0.001 |
| RDW-SD×LDL-C | 1.016(1.003~1.030) | 0.015 | 1.016(1.006~1.027) | 0.003 |
Table 5 Univariate Logistic regression analysis of coronary artery stenosis severity
| 因素 | 不合并T2DM的CHD组 | 合并T2DM的CHD组 | ||
|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 性别 | 0.779(0.263~2.308) | 0.653 | 0.571(0.229~1.425) | 0.230 |
| 年龄 | 0.965(0.919~1.014) | 0.160 | 0.935(0.882~0.993) | 0.027 |
| 吸烟史 | 0.838(0.349~2.013) | 0.693 | 0.693(0.381~1.509) | 0.355 |
| 饮酒史 | 1.073(0.277~4.161) | 0.919 | 1.625(0.484~5.454) | 0.432 |
| 高血压 | 0.792(0.321~1.952) | 0.612 | 2.386(1.098~5.184) | 0.028 |
| BMI | 0.963(0.827~1.123) | 0.634 | 0.980(0.855~1.124) | 0.775 |
| WBC计数 | 1.247(1.061~1.466) | 0.007 | 1.127(0.993~1.280) | 0.064 |
| Hb | 1.011(0.980~1.043) | 0.496 | 0.996(0.971~1.022) | 0.762 |
| PLT计数 | 1.009(1.001~1.017) | 0.031 | 0.998(0.991~1.005) | 0.641 |
| RDW-SD | 1.162(0.949~1.422) | 0.146 | 1.271(1.056~1.529) | 0.011 |
| RDW-CV | 1.047(0.513~2.137) | 0.900 | 1.284(0.722~2.283) | 0.395 |
| MCV | 1.104(0.981~1.241) | 0.100 | 1.091(0.997~1.194) | 0.058 |
| Scr | 1.028(0.996~1.060) | 0.087 | 1.012(0.993~1.032) | 0.221 |
| ALB | 1.121(0.977~1.286) | 0.103 | 1.024(0.912~1.149) | 0.690 |
| FBG | 1.475(0.999~2.180) | 0.051 | 1.193(1.041~1.368) | 0.011 |
| TG | 1.537(1.019~2.318) | 0.040 | 2.315(1.404~3.817) | 0.001 |
| TC | 2.108(1.256~3.538) | 0.005 | 1.997(1.316~3.030) | 0.001 |
| HDL-C | 2.467(0.371~16.425) | 0.350 | 1.193(0.296~4.810) | 0.804 |
| LDL-C | 1.936(1.092~3.433) | 0.024 | 1.853(1.178~2.914) | 0.008 |
| TyG | 2.934(1.203~7.158) | 0.018 | 10.448(3.501~31.178) | <0.001 |
| TyG×RDW-SD | 1.019(1.004~1.034) | 0.011 | 1.048(1.027~1.070) | <0.001 |
| TyG×MCV | 1.011(1.003~1.019) | 0.005 | 1.018(1.010~1.027) | <0.001 |
| RDW-SD×TC | 1.017(1.006~1.029) | 0.003 | 1.018(1.008~1.028) | <0.001 |
| RDW-SD×LDL-C | 1.016(1.003~1.030) | 0.015 | 1.016(1.006~1.027) | 0.003 |
| 组别 | 指标 | AUC(95%CI) | 灵敏度(%) | 特异度(%) | 最佳截断值 | P值 | DeLong检验 | |
|---|---|---|---|---|---|---|---|---|
| P值 | Z值 | |||||||
| 不合并T2DM的CHD组 | TyG | 0.610(0.485~0.734) | 29.6 | 93.5 | 9.59 | 0.083 | ||
| RDW-SD | 0.578(0.454~0.702) | 25.9 | 92.5 | 43.60 | 0.220 | |||
| TyG×RDW-SD | 0.650(0.536~0.763) | 85.2 | 45.2 | 359.44 | 0.018 | 0.343 | -0.949 | |
| TyG×MCV | 0.684(0.578~0.790) | 81.5 | 49.5 | 779.88 | 0.004 | |||
| RDW-SD×TC | 0.672(0.556~0.788) | 81.5 | 48.4 | 168.21 | 0.007 | 0.854 | -0.184 | |
| 合并T2DM的CHD组 | TyG | 0.742(0.649~0.834) | 58.1 | 83.1 | 9.72 | <0.001 | 0.153 | -1.429 |
| RDW-SD | 0.660(0.564~0.756) | 93.0 | 37.7 | 40.35 | 0.004 | <0.001 | -3.491 | |
| TyG×RDW-SD | 0.801(0.724~0.878) | 79.1 | 68.8 | 398.67 | <0.001 | |||
| TyG×MCV | 0.748(0.663~0.834) | 83.7 | 63.6 | 853.19 | <0.001 | 0.176 | -1.354 | |
| RDW-SD×TC | 0.701(0.608~0.795) | 95.3 | 33.8 | 148.21 | <0.001 | 0.057 | -1.903 | |
Table 6 Diagnostic efficacy of various indicators for judging the degree of coronary artery stenosis under different glucose metabolism statuses
| 组别 | 指标 | AUC(95%CI) | 灵敏度(%) | 特异度(%) | 最佳截断值 | P值 | DeLong检验 | |
|---|---|---|---|---|---|---|---|---|
| P值 | Z值 | |||||||
| 不合并T2DM的CHD组 | TyG | 0.610(0.485~0.734) | 29.6 | 93.5 | 9.59 | 0.083 | ||
| RDW-SD | 0.578(0.454~0.702) | 25.9 | 92.5 | 43.60 | 0.220 | |||
| TyG×RDW-SD | 0.650(0.536~0.763) | 85.2 | 45.2 | 359.44 | 0.018 | 0.343 | -0.949 | |
| TyG×MCV | 0.684(0.578~0.790) | 81.5 | 49.5 | 779.88 | 0.004 | |||
| RDW-SD×TC | 0.672(0.556~0.788) | 81.5 | 48.4 | 168.21 | 0.007 | 0.854 | -0.184 | |
| 合并T2DM的CHD组 | TyG | 0.742(0.649~0.834) | 58.1 | 83.1 | 9.72 | <0.001 | 0.153 | -1.429 |
| RDW-SD | 0.660(0.564~0.756) | 93.0 | 37.7 | 40.35 | 0.004 | <0.001 | -3.491 | |
| TyG×RDW-SD | 0.801(0.724~0.878) | 79.1 | 68.8 | 398.67 | <0.001 | |||
| TyG×MCV | 0.748(0.663~0.834) | 83.7 | 63.6 | 853.19 | <0.001 | 0.176 | -1.354 | |
| RDW-SD×TC | 0.701(0.608~0.795) | 95.3 | 33.8 | 148.21 | <0.001 | 0.057 | -1.903 | |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [1] | LI Wenzhe, YANG Yuqing, YANG Tingjie, GUO Yiming, CHEN Lulin, CAO Yudong, YUAN Jiangshu, YANG Honghui, WANG Che. Correlation Analysis between Triglyceride-glucose Index, Triglyceride-glucose-BMI and Vulnerable Plaques in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(23): 3287-3293. |
| [2] | LIAO Qiuhon, TAO Hong, YANG Xiaohui, YUAN Yonggui, LIN Shanshan, XU Wei, LI Yuxiu, PEI Yu. Prevalence of Depression and the Influencing Factors in Patients with Type 2 Diabetes Mellitus: a National Multicenter Cross-sectional Study [J]. Chinese General Practice, 2026, 29(12): 1558-1565. |
| [3] | LIU Yang, LIANG Fang, WU Ling, LI Wenlei, LI Pengfei. Diagnostic Value of Non-conventional Lipids and the Triglyceride-glucose Index in First-onset Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(11): 1422-1429. |
| [4] | LI Qiuchun, SU Ping, PANG Jinhong, CHEN Qiaoqiao, ZHAO Yingying, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association of Triglyceride Glucose Index with Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(09): 1129-1136. |
| [5] | Cardiovascular Internal Medicine Professional Committee of China Medical Education Association, Cardiovascular Health Medicine Branch of China International Exchange and Promotion Association for Medical Care. Expert Consensus on Early Screening and Prevention of Coronary Artery Disease in Young People [J]. Chinese General Practice, 2026, 29(02): 137-147. |
| [6] | FAN Xueming, YANG Ningning, ZHENG Zheng, WU Yumei, WANG Qi. Analysis of Correlation Factors and Predictive Value of Microvascular Complications in Patients with Type 2 Diabetes Mellitus Combined with Metabolic-associated Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(36): 4578-4585. |
| [7] | MI Lingyu, CHEN Lianxin, GAO Hengbo, WANG Bincheng. Predictive Value of Triglyceride-glucose Index for Prognosis in Patients with Pulmonary Embolism [J]. Chinese General Practice, 2025, 28(35): 4421-4429. |
| [8] | LIU Xiaoxue, LYU Liang, FENG Wanting, YANG Huifang, TENG Yilin, MA Tianpei, ZHANG Tao, JIANG Xia, LONG Lu, LIAO Jiaqiang, FAN Mengyu, WANG Chuan, YANG Dailan, LI Jiayuan, ZHANG Ben. Association of Longitudinal Trajectories of Triglyceride-glucose Index and Liver Stiffness Status in Elderly People [J]. Chinese General Practice, 2025, 28(29): 3668-3673. |
| [9] | CHEN Qiaoqiao, SU Ping, ZHAO Yingying, PANG Jinhong, SHI Jie, WANG Yaqian, LI Qiuchun, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association between Triglyceride-Glucose Index and Incident Cardiometabolic Multimorbidity in the Elderly: a Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(18): 2270-2277. |
| [10] | HAN Zheng, SUN Meng, FU Fanglin, PAN Yaojia, WANG Weiqiang. A Study on the Relationship between the Triglyceride-Glucose Index and Cardiometabolic Multimorbidity in Individuals Aged 50 and Above [J]. Chinese General Practice, 2025, 28(18): 2278-2284. |
| [11] | HU Guiping, LIN Ping, ZHAO Zhenjuan, WANG Yini, YAN Mingqiang, SUN Xiao. Relationship between Dietary Inflammatory Potential and Severity of Coronary Artery Disease in Acute Coronary Syndrome Patients [J]. Chinese General Practice, 2024, 27(24): 3000-3006. |
| [12] | HOU Qinchuan, ZHANG Rui, LI Binghong, ZHANG Huiwang, ZHANG Beibei, YONG Tao, LIU Yuping, SHUAI Ping. A Retrospective Cohort Study on the Relationship between Triglyceride-Glucose Index and Its Combination with Obesity Indices and Chronic Kidney Disease in Adults [J]. Chinese General Practice, 2024, 27(22): 2731-2738. |
| [13] | PAN Yaojia, WANG Weiqiang, YI Weizhuo, GAO Bing, FU Fanglin, HAN Zheng, SUN Meng, DONG Yaqin, GU Huaicong. Relationship between Triglyceride-glucose Index and Risk of Cardiovascular Diseases in Middle-aged Obese Residents of Different Genders [J]. Chinese General Practice, 2023, 26(29): 3628-3635. |
| [14] | ZUMURETI ·Abudukeyimu, MA Yanlin, ZHU Kairui, LIU Fang, LI Xia. Correlation of Early Growth Response 3 and Interleukin 6 Expression Levels with Coronary Heart Disease [J]. Chinese General Practice, 2023, 26(24): 3016-3021. |
| [15] | GOU Dengqun, ZHANG Lu, XU Yuanli, JIANG Mingjiao, WU Hemei, TAO Ming. Neutrophil-to-lymphocyte Ratio and Red Cell Distribution Width as Potential Biomarkers of Frailty: a Scoping Review [J]. Chinese General Practice, 2023, 26(17): 2169-2175. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||